Home About Chiesi     History     Research and Development     B Corp     Sustainability Report Therapeutic Areas      SOLUNUM      NEONATOLOJİ      NADİR HASTALIKLAR Products     Chiesi Products Services     Customer Service     Adverse Effect Notification Working at Chiesi Sustainability     Our Commitment & Activities     Chiesi Suppliers Code of Conduct     Chiesi Code of Conduct Contact
  • Home
  • |
  • SpeakUp&BeHeard
  • |
  • Adverse Effect Notification
  • |
  • Chiesi Group
  • TR
  • EN
Welcome to Chiesi!
Turkiye
Enter at least 3 characters
  • About Chiesi
    • History
    • Research and Development
    • B Corp
    • Sustainability Report
  • Therapeutic Areas
    • RESPIRATORY
    • NEONATOLOGY
    • Rare Diseases
  • Products
    • Chiesi Products
  • Services
    • Customer Service
    • Adverse Effect Notification
  • Working at Chiesi
  • Sustainability
    • Our Commitment & Activities
    • Chiesi Suppliers Code of Conduct
    • Chiesi Code of Conduct
  • Contact
Home page > Products > Chiesi products

Authorize the processing of personal data
Edit email address
Invalid email
Email Sent
Authorize the processing of personal data
  • Chiesi Ürünleri

    • Curosurf
    • Cycladol
    • Ferriprox
    • Foster
    • Foster Nexthaler
    • Hyaneb
    • Iperten
    • Kengrexal
    • Peyona
    • Rinoclenil

Chiesi Products

  • A-C
  • D-F
  • G-J
  • K-M
  • N-P
  • Q-S
  • T-V
  • W-Z
  • Curosurf
    Active ingredient: Poraktant alfa
     
    Cycladol
    Active ingredient: Piroksikam-beta-siklodekstrin
     
  • Ferriprox
    Active ingredient Deferiprone
     
    Foster
    Active ingredient Beklometazon dipropiyonat /Formoterol fumarat
     
    Foster Nexthaler
    Active ingredient Beklometazon dipropiyonat / Formoterol fumarat dihidrat
     
  • Hyaneb
    Active ingredient %7 Sodyum Klorür, %0,1 Sodyum Hyaluronat
     
    Iperten
    Active ingredient Manidipin Hidroklorür
     
  • Kengrexal
    Active ingredient Kangrelor tetrasodium
     
  • Peyona
    Active ingredient Kafein sitrat
     
  • Rinoclenil
    Active ingredient Beklometazon dipropiyonat
     
© 2025 Chiesi İlaç Ticaret A.Ş
İnkılap Mh. Dr. Adnan Büyükdeniz Cd.
Akkom Ofis Park 3. Blok Kelif Plaza No:2 Kat:6 İç Kapı No:7 34768
Ümraniye İstanbul Türkiye
Tel: 0212 370 91 00
Faks: 0212 370 91 27
info.tr@chiesi.com
  • Site map
  • Accessibility
  • Privacy
  • Cookie
  • Terms of use
  • Privacy-SpeakUp&BeHeard
  • SpeakUp&BeHeard
  • Adverse Effect Notification
  • Credits
CHIESI ON THE WEB
Austria
Chiesi Pharmaceuticals GmbH
Belgium
Chiesi sa
Brazil
Chiesi Farmacêutica Ltda
Bulgaria
Chiesi Bulgaria Ltd.
China
Chiesi Pharmaceutical (Shanghai) Co., Ltd
Czech Republic
Chiesi CZ s.r.o.
France
Chiesi S.A.
Germany
Chiesi GmbH
Greece
Chiesi Hellas Pharmaceuticals S.A.
Hungary
Chiesi Hungary Kft.
Italy
-
Mexico
Chiesi Mexico S.A. de C.V.
Pakistan
Chiesi Pharmaceuticals (Pvt) Limited
Poland
Chiesi Polonia
Romania
Chiesi România S.r.l.
Russian Federetion
Chiesi Pharmaceuticals LLC
Slovak Republic
Chiesi Slovakia s.r.o
Slovenia
Chiesi Slovenija, d.o.o
Spain
Chiesi España S.A.
Sweden
Chiesi Pharma AB
The Netherlands
Chiesi Pharmaceuticals B.V.
Turkey
Chiesi İlaçTicaret Limited Sirketi  A.Ş.
United Kingdom
Chiesi Ltd
United States
Chiesi Usa Inc.